rs550469990
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_004260.4(RECQL4):c.2426G>A(p.Gly809Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000187 in 1,590,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G809R) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2426G>A | p.Gly809Glu | missense_variant | 14/21 | ENST00000617875.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2426G>A | p.Gly809Glu | missense_variant | 14/21 | 1 | NM_004260.4 | P1 | |
RECQL4 | ENST00000621189.4 | c.1355G>A | p.Gly452Glu | missense_variant | 13/20 | 1 | |||
ENST00000580385.1 | n.272-351C>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
RECQL4 | ENST00000534626.6 | c.635-117G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000401 AC: 61AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000327 AC: 71AN: 217010Hom.: 0 AF XY: 0.000397 AC XY: 48AN XY: 121052
GnomAD4 exome AF: 0.000164 AC: 236AN: 1438238Hom.: 0 Cov.: 47 AF XY: 0.000169 AC XY: 121AN XY: 714510
GnomAD4 genome ? AF: 0.000401 AC: 61AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74434
ClinVar
Submissions by phenotype
Rothmund-Thomson syndrome type 2 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Mar 04, 2021 | The RECQL4 c.2426G>A (p.Gly809Glu) missense change is present in gnomAD at a maximum non-founder subpopulation frequency of 0.026% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/8-145738638-C-T?dataset=gnomad_r2_1). In silico tools predict a deleterious effect of this variant on protein function (PP3), but to our knowledge these predictions have not been confirmed by functional assays. To our knowledge, this variant has not been reported in individuals with RECQL4-associated disorders. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: PP3. - |
Likely benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 23, 2022 | DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.2426G>A, in exon 14 that results in an amino acid change, p.Gly809Glu. This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.34% in the Ashkenazi Jewish subpopulation (dbSNP rs550469990). The p.Gly809Glu change affects a highly conserved amino acid residue located in a domain of the RECQL4 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Gly809Glu substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Gly809Glu change remains unknown at this time. Homozygous or compound heterozygous pathogenic variants in RECQL4 have been identified in individuals with Baller-Gerold syndrome [OMIM #218600], which is characterized by craniosynostosis and radial aplasia. Biallelic pathogenic variants in RECQL4 are also associated with two additional overlapping conditions, Rothmund-Thompson syndrome [OMIM #268400] and RAPADILINO syndrome [OMIM #266280]. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.2426G>A (p.G809E) alteration is located in exon 14 (coding exon 14) of the RECQL4 gene. This alteration results from a G to A substitution at nucleotide position 2426, causing the glycine (G) at amino acid position 809 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 07, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Oct 15, 2021 | - - |
RECQL4-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 27, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Baller-Gerold syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 20, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at